Needle Free Injection Market Opportunities, Growth and Forecast Report 2025

Posted by rekha on September 3rd, 2019

Precision Business Insights (PBI) in its report titled “Global Needle Free Injection Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2024” assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global needle free injection market was valued at US$ XX Mn in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the incidence of cancer, diabetes and other infectious diseases, technological advancements in providing pain free medication, launch of newer therapeutics as pain less injectables, government initiatives to prevent the cancer, diabetes and advanced healthcare services are expected to drive the global needle free injection market. However, high cost for the production, huge developmental costs, stringent regulations associated with such devices, and development of new designs, are anticipated to hinder the revenue share of global needle free injection market.

Global needle free injection market segmented on the basis By Type of medicament, By Product, By Technology, By Site of Delivery, By Application,By Source of Power,  By End Use, By Geography.

For request sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=36215

Fillable Needle-Free Injectors Dominates the Global Needle Free Injection Market

Based on product type of needle free injectors, global needle free injection market segmented into prefilled needle-free injectors and fillable needle-free injectors. Fillable Needle-Free Injectors dominated the global needle free injection market in 2018 and estimated to dominate over the forecast period owing to innovation of newer technologies by the companies, rise in awareness about the needle free injection among the people, and patent filings by the market players on different technologies associated with the needle free injectors are surge the market over the forecast years. However, a slow growth rate observed for the Prefilled Needle-Free Injectors due to their limited applications and storage problems.

North America Leads the Global Needle Free Injection Market

PBI’s global needle free injection market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to advance healthcare system, presence of skilled professionals, launch of innovative strategies into market, and rise in healthcare expenditure are propel the market. Asia Pacific needle free injection market projected to exhibit significant growth due to entry of market players into emerging countries such as India and China and development in healthcare infrastructure boost the market.

Launch of newer technologies of needle free injector products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

Global needle free injection market further reveals that the key players increasingly adopting strategies such as launch of newer technologies of needle free injector products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In May 02, 2016, PLYMOUTH MEETING, Pa., (GLOBE NEWSWIRE) Inovio Pharmaceuticals, Inc. (NASDAQ:INO) acquired BioJect Medical Technologies Inc.’s assets.The acquisition intensified Inovio Pharmaceuticals, Inc’s collection of investments of needle free injection market which have major applications in diabetes, cancer and infectious diseases. This acquisition is helping Inovio Pharmaceuticals, Inc to fortify its position in the global market.

Key player’s profiles in the report are

• Antares Pharma, Inc., (U.S.)
• Crossject needle-free injection systems ( France)
• D'Antonio Consultants International Inc. (U.S.)
• European Pharma Group (Netherlands)
• Endo Pharmaceuticals Inc. (Ireland)
• INJEX Pharma GmBH. (Germany)
• Medical International Technology, Inc., (Canada)
• National Medical Products Inc., (Saudi Arabia)
• Mika Medical Co., (Korea)
• PenJet Corporation. (U.S.)

Detailed Segmentation

By Type of medication

• Liquid-Based Needle Free Injectors
• Projectile/Depot-Based Needle-Free Injectors
• Powder-Based Needle Free Injectors

By product

• Prefilled Needle-Free Injectors
• Fillable Needle-Free Injectors

 By Application

• Vaccine Delivery
• Insulin Delivery
• Pain Management
• Other Applications

By End User

• Hospitals & Clinics
• Home Care Settings
• Research laboratories
• Others

By Site of Delivery 

• Subcutaneous Injectors
• Intramuscular Injectors
• Intradermal Injectors

By Technology 

• Jet-Based Needle-Free Injectors
• Spring-Based Needle-Free Injectors 
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

By Source of Power

• Spring-based Injector Systems
• Gas Propelled/Air Forced Injector Systems

Geography

• North America
  • U.S
• Canada
• Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
• Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

For more information: https://www.precisionbusinessinsights.com/market-reports/global-needle-free-injection-market/